跳至主要内容
临床试验/NCT06060548
NCT06060548招募中不适用

Role of a Novel Implantable Loop Recorder in the Management of Premature Ventricular Contractions

Kansas City Heart Rhythm Research Foundation6 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
50
试验地点
6
主要终点
Identification of unrecognized myocarditis

研究概览

简要总结

This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.

详细描述

This study is intended to monitor patients presenting with Premature Ventricular Contractions (PVCs) and ventricular arrhythmias using implantable loop recorders (ILRs) from the time of their initial presentation of PVCs to assess for the incidence of all cardiac arrhythmias detected with long term monitoring in this population. It is also intended to evaluate for clinical, biomarker and radiological evidence of myocarditis in this cohort to understand association with incident arrhythmias and understand the role of implantable loop recorders (ILRs)in managing these patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients > 18 years of age
  • Have a Medtronic LINQ II ILR
  • Willing and able to give written informed consent

排除标准

  • History of myocardial infarction
  • Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronary angiography or Computed tomography angiography (CTA).
  • History of cardiac arrest
  • With existing implantable defibrillators
  • Currently pregnant

结局指标

主要结局

Identification of unrecognized myocarditis

时间窗: 12 Months

Identification of unrecognized myocarditis in patients presenting PVCs with positive FDG-PET \[fluorodeoxyglucose (FDG)-positron emission tomography (PET)\] scanning.

Evaluation of efficacy of immunosuppressive therapy - LVEF improvement

时间窗: 12 Months

Evaluation of efficacy of immunosuppressive therapy in patients with NICM by documenting improvement in LVEF compared to their baseline LVEF.

Evaluation of efficacy of immunosuppressive therapy - PVC burden reduce

时间窗: 12 Months

Evaluation of efficacy of immunosuppressive therapy in patients with NICM with PVCs in reducing PVC burden as compared to their baseline PVC burden.

Associated atrial and ventricular arrhythmias

时间窗: 12 Months

Assessing incidence of associated atrial and ventricular arrhythmias as detected with ILR recordings in patients with apparently idiopathic PVCs.

次要结局

未报告次要终点

研究者

发起方
Kansas City Heart Rhythm Research Foundation
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Role of Novel ILR in the Management of PVCs | 临床试验